The global Optima HIV allocative efficiency model: targeting resources in efforts to end AIDS.

Kelly, Sherrie L; Martin-Hughes, Rowan; Stuart, Robyn M; Yap, Xiao F; Kedziora, David J; Grantham, Kelsey L; Hussain, S Azfar; Reporter, Iyanoosh; Shattock, Andrew J; Grobicki, Laura; Haghparast-Bidgoli, Hassan; Skordis-Worrall, Jolene; Baranczuk, Z; Keiser, O; Estill, J; Petravic, Janka; Gray, Richard T; Benedikt, Clemens J; Fraser, Nicole; Gorgens, Marelize; ... (2018). The global Optima HIV allocative efficiency model: targeting resources in efforts to end AIDS. The Lancet HIV, 5(4), e190-e198. Elsevier 10.1016/S2352-3018(18)30024-9

[img]
Preview
Text
Sherrie LancetHIV 2018.pdf - Accepted Version
Available under License Creative Commons: Attribution-Noncommercial-No Derivative Works (CC-BY-NC-ND).

Download (919kB) | Preview

BACKGROUND

To move towards ending AIDS by 2030, HIV resources should be allocated cost-effectively. We used the Optima HIV model to estimate how global HIV resources could be retargeted for greatest epidemiological effect and how many additional new infections could be averted by 2030.

METHODS

We collated standard data used in country modelling exercises (including demographic, epidemiological, behavioural, programmatic, and expenditure data) from Jan 1, 2000, to Dec 31, 2015 for 44 countries, capturing 80% of people living with HIV worldwide. These data were used to parameterise separate subnational and national models within the Optima HIV framework. To estimate optimal resource allocation at subnational, national, regional, and global levels, we used an adaptive stochastic descent optimisation algorithm in combination with the epidemic models and cost functions for each programme in each country. Optimal allocation analyses were done with international HIV funds remaining the same to each country and by redistributing these funds between countries.

FINDINGS

Without additional funding, if countries were to optimally allocate their HIV resources from 2016 to 2030, we estimate that an additional 7·4 million (uncertainty range 3·9 million-14·0 million) new infections could be averted, representing a 26% (uncertainty range 13-50%) incidence reduction. Redistribution of international funds between countries could avert a further 1·9 million infections, which represents a 33% (uncertainty range 20-58%) incidence reduction overall. To reduce HIV incidence by 90% relative to 2010, we estimate that more than a three-fold increase of current annual funds will be necessary until 2030. The most common priorities for optimal resource reallocation are to scale up treatment and prevention programmes targeting key populations at greatest risk in each setting. Prioritisation of other HIV programmes depends on the epidemiology and cost-effectiveness of service delivery in each setting as well as resource availability.

INTERPRETATION

Further reductions in global HIV incidence are possible through improved targeting of international and national HIV resources.

FUNDING

World Bank and Australian NHMRC.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Pre-clinic Human Medicine > Institute of Social and Preventive Medicine (ISPM)

UniBE Contributor:

Baranczuk, Zofia, Keiser, Olivia, Estill, Janne Anton Markus

Subjects:

600 Technology > 610 Medicine & health
300 Social sciences, sociology & anthropology > 360 Social problems & social services

ISSN:

2352-3018

Publisher:

Elsevier

Language:

English

Submitter:

Tanya Karrer

Date Deposited:

01 Oct 2018 09:52

Last Modified:

05 Dec 2022 15:18

Publisher DOI:

10.1016/S2352-3018(18)30024-9

PubMed ID:

29540265

BORIS DOI:

10.7892/boris.120146

URI:

https://boris.unibe.ch/id/eprint/120146

Actions (login required)

Edit item Edit item
Provide Feedback